6-K//Foreign company update
Oasmia Pharmaceutical AB 6-K
Accession 0001144204-19-033035
CIK 0001607245other
Filed
Jun 27, 8:00 PM ET
Accepted
Jun 28, 4:05 PM ET
Size
768.0 KB
Accession
0001144204-19-033035
Documents
- 6-Ktv524514_6k.htmPrimary
FORM 6-K
- EX-99.1tv524514_ex99-1.htm
EXHIBIT 99.1
- EX-99.2tv524514_ex99-2.htm
EXHIBIT 99.2
- EX-99.3tv524514_ex99-3.htm
EXHIBIT 99.3
- EX-99.4tv524514_ex99-4.htm
EXHIBIT 99.4
- GRAPHICtv524514_ex99-1img1.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img1.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img2.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img3.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img4.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img5.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img6.jpg
GRAPHIC
- GRAPHICtv524514_ex99-2img7.jpg
GRAPHIC
- GRAPHICtv524514_ex99-3img1.jpg
GRAPHIC
- GRAPHICtv524514_ex99-4img1.jpg
GRAPHIC
Issuer
Oasmia Pharmaceutical AB
CIK 0001607245
Entity typeother
IncorporatedSweden
Related Parties
1- filerCIK 0001607245
Filing Metadata
- Form type
- 6-K
- Filed
- Jun 27, 8:00 PM ET
- Accepted
- Jun 28, 4:05 PM ET
- Size
- 768.0 KB